Dr. Daniel Veres
Daniel graduated as a medical doctor at Semmelweis University, Hungary, finishing his PhD in the field of cancer signaling and network biology. He has been an active member of LINK-Group – a multidisciplinary research group of complex systems, network topology and dynamics- since 2009. His academic research focuses on the spatial organization of cancer signaling and protein-protein interaction networks, and their role in the systems level understanding of cancer initiation and progression. He is a Co-founder and Chief Medical Officer of Turbine.AI, a startup building Simulated Cells, accurately modelling cell biology and can identify the best drug to target a specific tumor with, find complex biomarkers and design combination therapies by performing millions of simulated experiments each day. Entering the market less than a year ago, Turbine is already working with top 20 pharma companies and renowned cancer research institutes as the University of Cambridge. As the CMO of Turbine, Daniel focuses on the facilitation of the in silico – in vitro – in vivo translation of simulation results into the highest possible impact on drug discovery, resulting in medical and patient benefit.